M. Sibbering

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
M Sibbering, M. Sibbering, Mark Sibbering
Publication record
49 papers · 2,579 citations · H-index 13

PAPERS

EAST MIDLANDS BREAST PAIN PATHWAY - AN EVALUATION OF COMMUNITY BREAST PAIN CLINICS ACROSS THE EAST MIDLANDS CANCER ALLIANCE
20240 citationsauthor #6
Follow up safety data from the Derbyshire pilot of community breast pain clinics
20240 citationsauthor #1
Community breast pain clinics can provide safe, quality care for women presenting with breast pain
20241 citationsauthor #1
Family history risk assessment in two-week-wait breast clinics – An audit of the service at University Hospitals of Derby and Burton (UHDB)
20240 citationsauthor #4
Positive patient feedback following breast pain management in community breast pain clinics
20240 citationsauthor #9
Is Breast Specimen Weight An Accurate Surrogate For Volume? A 3-Dimensional Analysis.
20240 citationsauthor #5
HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer
202215 citationsauthor #96
Cohort profile of the Sloane Project: methodology for a prospective UK cohort study of >15 000 women with screen-detected non-invasive breast neoplasia
20228 citationsauthor #9
Transforming the 2-week wait (2WW) pathway: management of breast pain in primary care
20227 citationsauthor #5
Impact of the menstrual cycle on commercial prognostic gene signatures in oestrogen receptor-positive primary breast cancer
20213 citationsauthor #16
P071: Nipple discharge - Blood staining should be the most important factor in surgical decision making?
20200 citationsauthor #2
Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial
2020169 citationsauthor #10
P067: Assessment of burnout among breast surgeons in the United Kingdom
20201 citationsauthor #7
Residual lymph node tumour burden following removal of a single axillary sentinel lymph with macrometastatic disease in women with screen-detected invasive breast cancer
20203 citationsauthor #3
Changes in expression of hormone-regulated and proliferation-associated genes across the menstrual cycle in oestrogen receptor-positive breast cancer
20200 citationsauthor #17
Management of breast cancer: basic principles
20199 citationsauthor #1
Menstrual cycle associated changes in hormone-related gene expression in oestrogen receptor positive breast cancer
201918 citationsauthor #17
Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project.
201868 citationsauthor #17
Breast Cancer Screening
20182 citationsauthor #2
Abstract GS1-03: Peri-operative aromatase inhibitor treatment in determining or predicting longterm outcome in early breast cancer – The POETIC* Trial (CRUK/07/015)
201827 citationsauthor #11
Treatment and outcomes from a large, prospective, national longitudinal cohort study of screen detected ductal carcinoma in situ (DCIS).
20161 citationsauthor #16
LAUNCH OF THE BREAST SCREENING AFTER RADIOTHERAPY DATASET - AN ENGLAND WIDE INITIATIVE TO IMPROVE SCREENING FOR BREAST CANCER IN 9,000 WOMEN AT HIGH RISK FOLLOWING RADIOTHERAPY TO BREAST TISSUE UNDER AGE 36
20160 citationsauthor #9
34. Clinical audit of the assessment of osteoporosis by axial DXA scanning and treatment/prevention of bone loss in post menopausal women, commenced on adjuvant treatment for breast cancer with aromatase inhibitors
20150 citationsauthor #1
Cancers diagnosed, end points and efficacy
20130 citationsauthor #14
Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study.
201313 citationsauthor #14
Information sheet for primary care staff
20130 citationsauthor #14
Protocol of FH01
20130 citationsauthor #14
Radiology and pathology reviews
20130 citationsauthor #14
Information sheet used in England and Wales for potential FH01 recruits
20130 citationsauthor #14
FH01 blood study protocol
20130 citationsauthor #14
Implications of the results
20131 citationsauthor #14
Baseline characteristics of the recruited population and the Age Trial comparison population
20130 citationsauthor #14
Follow-up data
20135 citationsauthor #14
Surveillance activity and outcomes
20130 citationsauthor #14
Design, planned analysis and study size
20130 citationsauthor #14
Surgeon and Breast Unit Volume-Outcome Relationships in Breast Cancer Surgery and Treatment
201349 citationsauthor #5
Background to and evolution of FH01
20130 citationsauthor #14
Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.
20061,640 citationsauthor #12
Role of routine preoperative lymphoscintigraphy in sentinel node biopsy for breast cancer.
2005107 citationsauthor #8
Clinical Guidelines and Evidence Report for The classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care.
20048 citationsauthor #14
Sentinel lymph node biopsy in male breast cancer patients.
200472 citationsauthor #5
Sentinel lymph node biopsy in patients with multifocal breast cancer.
200490 citationsauthor #8
DNA fingerprinting of benign and malignant breast lesions.
19962 citationsauthor #1
High levels of allele loss at the FHIT and ATM genes in non-comedo ductal carcinoma in situ and grade I tubular invasive breast cancers.
199675 citationsauthor #3
Ductal carcinoma in situ of the breast: correlation between mammographic and pathologic findings.
1994125 citationsauthor #4
Screening-detected and symptomatic ductal carcinoma in situ: mammographic features with pathologic correlation.
199457 citationsauthor #4
An analysis of benign lesions during the nottingham breast screening programme
19930 citationsauthor #3
Pathological-radiological correlations in ductal carcinoma in situ (DCIS)
19931 citationsauthor #4
A comparison of the mammographic features of screening detected and symptomatic ductal carcinoma in situ (DCIS)
19931 citationsauthor #5

TIMELINE

1993 2 citations

1994 182 citations

1996 77 citations

2004 170 citations

2005 107 citations

2006 1,640 citations

2013 68 citations

2015 0 citations

2016 1 citations

2018 97 citations

2019 27 citations

2020 173 citations

2021 3 citations

2022 30 citations

2024 1 citations

M. Sibbering

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT